Anna Svärd

914 total citations
42 papers, 590 citations indexed

About

Anna Svärd is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Nephrology. According to data from OpenAlex, Anna Svärd has authored 42 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Rheumatology, 14 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Nephrology. Recurrent topics in Anna Svärd's work include Rheumatoid Arthritis Research and Therapies (16 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Systemic Lupus Erythematosus Research (13 papers). Anna Svärd is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Monoclonal and Polyclonal Antibodies Research (14 papers) and Systemic Lupus Erythematosus Research (13 papers). Anna Svärd collaborates with scholars based in Sweden, Finland and United Kingdom. Anna Svärd's co-authors include Alf Kastbom, Thomas Skogh, Valgerður Sigurðardóttir, Mats Dehlin, L. Jacobsson, K. Martinsson, Yngve Sommarin, Maria K. Söderlin, Lars Klareskog and Camilla Bengtsson and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Anna Svärd

37 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Svärd Sweden 14 337 172 143 129 68 42 590
Vasiliki Galanopoulou Greece 14 237 0.7× 49 0.3× 22 0.2× 148 1.1× 65 1.0× 23 641
Alan R. Erickson United States 9 264 0.8× 18 0.1× 52 0.4× 40 0.3× 54 0.8× 22 461
Dannette S. Johnson United States 11 529 1.6× 81 0.5× 19 0.1× 129 1.0× 34 0.5× 12 784
Judith Sautner Austria 13 307 0.9× 16 0.1× 43 0.3× 85 0.7× 90 1.3× 39 494
Andrese Aline Gasparin Brazil 12 172 0.5× 18 0.1× 49 0.3× 112 0.9× 34 0.5× 31 324
D. Tin Canada 15 592 1.8× 53 0.3× 15 0.1× 95 0.7× 19 0.3× 59 731
Ivan Padjen Croatia 10 142 0.4× 30 0.2× 15 0.1× 81 0.6× 19 0.3× 29 324
Nataliya Milman Canada 12 293 0.9× 17 0.1× 31 0.2× 54 0.4× 29 0.4× 31 475
Sedat Yılmaz Türkiye 14 202 0.6× 16 0.1× 18 0.1× 101 0.8× 87 1.3× 100 630
Valerie Klusas Branch United States 10 380 1.1× 199 1.2× 16 0.1× 311 2.4× 18 0.3× 11 716

Countries citing papers authored by Anna Svärd

Since Specialization
Citations

This map shows the geographic impact of Anna Svärd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Svärd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Svärd more than expected).

Fields of papers citing papers by Anna Svärd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Svärd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Svärd. The network helps show where Anna Svärd may publish in the future.

Co-authorship network of co-authors of Anna Svärd

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Svärd. A scholar is included among the top collaborators of Anna Svärd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Svärd. Anna Svärd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Svärd, Anna, et al.. (2025). Lived Experiences of Older LGBTQI+ Adults Aged 60 or Older: A Systematic Review and Qualitative Synthesis. Journal of Homosexuality. 73(1). 26–63.
3.
Svärd, Anna, Riccardo LoMartire, K. Martinsson, et al.. (2024). Presence and Immunoreactivity of Aggregatibacter actinomycetemcomitans in Rheumatoid Arthritis. Pathogens. 13(5). 368–368. 3 indexed citations
4.
Svärd, Anna, Alf Kastbom, Barbara Potempa, et al.. (2023). Antibodies against Porphyromonas gingivalis in serum and saliva and their association with rheumatoid arthritis and periodontitis. Data from two rheumatoid arthritis cohorts in Sweden. Frontiers in Immunology. 14. 1183194–1183194. 11 indexed citations
5.
Martinsson, K., Andrea Di Matteo, Carina Öhman, et al.. (2023). Antibodies to leukotoxin A from the periodontal pathogen Aggregatibacter actinomycetemcomitans in patients at an increased risk of rheumatoid arthritis. Frontiers in Medicine. 10. 1176165–1176165. 6 indexed citations
7.
Sigurðardóttir, Valgerður, Anna Svärd, L. Jacobsson, & Mats Dehlin. (2022). Gout in Dalarna, Sweden – a population-based study of gout occurrence and compliance to treatment guidelines. Scandinavian Journal of Rheumatology. 52(5). 498–505. 8 indexed citations
9.
Wang, Yan, Katy A. Lloyd, Ioannis N. Melas, et al.. (2019). Rheumatoid arthritis patients display B-cell dysregulation already in the naïve repertoire consistent with defects in B-cell tolerance. Scientific Reports. 9(1). 19995–19995. 50 indexed citations
10.
Sigurðardóttir, Valgerður, et al.. (2018). Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy. Arthritis Research & Therapy. 20(1). 108–108. 34 indexed citations
11.
Svärd, Anna, Jouni Lahti, Minna Mänty, et al.. (2018). Joint Association of Overweight and Common Mental Disorders With Diagnosis-Specific Disability Retirement. Journal of Occupational and Environmental Medicine. 60(11). 979–984. 3 indexed citations
12.
Sigurðardóttir, Valgerður, et al.. (2017). SAT0173 Switching from reference product etanercept to the biosimilar sb4 in a real-life setting: follow-up of 147 patients. Annals of the Rheumatic Diseases. 76. 835–835. 13 indexed citations
13.
Biermann, Mona, Jasmin Knopf, Alf Kastbom, et al.. (2017). Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy. Clinical & Experimental Immunology. 189(3). 372–382. 22 indexed citations
14.
Svärd, Anna, Jouni Lahti, E Roos, et al.. (2017). Obesity, change of body mass index and subsequent physical and mental health functioning: a 12-year follow-up study among ageing employees. BMC Public Health. 17(1). 744–744. 16 indexed citations
15.
Sigurðardóttir, Valgerður, et al.. (2017). Work disability in gout: a population-based case–control study. Annals of the Rheumatic Diseases. 77(3). 399–404. 23 indexed citations
16.
Dehlin, Mats, et al.. (2016). Incidence and prevalence of gout in Western Sweden. Arthritis Research & Therapy. 18(1). 164–164. 80 indexed citations
17.
Martinsson, K., et al.. (2016). Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking. Arthritis Research & Therapy. 18(1). 119–119. 35 indexed citations
18.
Svärd, Anna. (2014). Circulating and Mucosal Antibodies to Citrullinated Antigens in Rheumatoid Arthritis. Linköping University Electronic Press eBooks. 1 indexed citations
19.
Svärd, Anna, Alf Kastbom, Yngve Sommarin, & Thomas Skogh. (2012). Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis. Immunobiology. 218(2). 232–237. 29 indexed citations
20.
Svärd, Anna, et al.. (2008). Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project. Arthritis Research & Therapy. 10(4). R75–R75. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026